-
Hoofddorp, Netherlands – [08/04/2025] – Nordic Group B.V., an international pharmaceutical company operating as Nordic Pharma, announced today that Lacrifill®, a novel therapy for dry eye, has just received CE...
ADVERTISEMENT
ADVERTISEMENT
NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
Hoofddorp, Netherlands – [08/04/2025] – Nordic Group B.V., an international pharmaceutical company operating as Nordic Pharma, announced today that Lacrifill®, a novel therapy for dry eye, has just received CE...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT